Overview

Detailed Summary

Constronics Infra Limited, formerly Invicta Meditek Limited, transitioned from a pharma company to focus on construction and infrastructure. It was established in 1992 and shifted its main objective in 2018.
The company engages in various construction projects and trades materials like Blue Metals and M-Sand. This marked a significant pivot from its previous pharmaceutical operations to become a player in infrastructure.
Constronics Infra's transition highlights a strategic shift driven by new management objectives, signaling an adaptive and possibly opportunistic approach to market needs.
Originally launched a unique BP knee replacement system in 2007, demonstrating prior involvement in medical technology before its strategic pivot.

Sector: Commercial Services & Supplies
Industry: Trading & Distributors
Market Cap: 64 Cr
Volatility: Low Risk
P/E Ratio: 11.2
Industry P/E: 21.3
PEG Ratio: 0.1
P/B Ratio: 1.8
52W High: 70.99
52W Low: 40.70

Sales CAGR

1Y: 6519.48%
3Y: 186.29%
5Y: 93.42%
10Y: —

Profit CAGR

1Y: 334.72%
3Y: 161.67%
5Y: 101.98%
10Y: —

ROE

TTM: —
3Y: 9.78%
5Y: 9.97%
10Y: 9.17%

ROCE

TTM: —
3Y: 11.59%
5Y: 11.19%
10Y: 10.25%

Technicals

‌

Forecasts

Peers

Services Services Trading & Distributors

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
GANVERSE		27.86	69 Cr	-3.29	1.68	0.00	0.00	0.00	-11.03
GENPHARMA		1.08	65 Cr	-36.00	0.99	0.00	0.80	2.48	-0.85
CONSTRONIC		51.40	64 Cr	11.20	1.83	0.00	—	—	0.00
IFL		0.35	61 Cr	0.58	0.46	0.00	7.04	9.11	4.02
CALLISTA		209.00	61 Cr	-54.15	0.00	0.00	84.76	-112.97	-146.25
HIRAUTO		215.15	59 Cr	146.36	4.09	0.00	5.40	8.94	0.38
PULSRIN		1.45	59 Cr	17.76	1.22	0.00	6.34	6.34	11.77
Median: 7 Co.	—	27.86	61 Cr	0.58	1.22	0.00	5.87	4.41	0.00

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2024	Sep 2025	Dec 2025
Sales	16	20	9.05
Expenses	15	18	8.94
Operating Profit	1.09	1.48	0.11
OPM %	6.87	7.52	1.22
Other Income	0.80	0.32	0.39
Interest	0.11	-0.04	0.02
Depreciation	0.10	0.06	0.06
Profit Before Tax	1.68	1.78	0.43
Tax %	42.86	25.28	27.91
Net Profit	0.96	1.33	0.31
EPS in Rs	0.66	0.86	0.20

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	0.00	0.00	0.55	1.88	1.53	2.17	0.82	0.77	51	61
Expenses	0.09	0.30	0.57	1.79	1.61	2.06	0.72	0.45	48	57
Operating Profit	-0.09	-0.30	-0.02	0.09	-0.08	0.12	0.10	0.32	3.17	4.11
OPM %	—	—	-4.12	4.93	-5.46	5.40	12.39	41.45	6.21	6.75
Other Income	0.00	0.17	0.00	0.00	0.01	0.01	0.03	0.49	1.54	2.13
Interest	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.14	0.21
Depreciation	0.00	0.00	0.00	0.00	0.00	0.02	0.02	0.03	0.19	0.24
Profit Before Tax	-0.09	-0.13	-0.02	0.09	-0.08	0.10	0.09	0.77	4.37	5.78
Tax %	0.00	0.00	0.00	0.00	0.00	-75.13	40.29	7.14	28.41	27.34
Net Profit	-0.09	-0.13	-0.02	0.09	-0.08	0.17	0.06	0.72	3.13	4.20
EPS in Rs	-0.07	-0.10	-0.02	0.07	-0.06	0.14	0.06	0.58	2.40	4.59
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	7.21	7.21	7.21	7.21	7.21	7.21	7.21	7.21	7.21	13
Reserves	-6.54	-7.06	-7.18	-7.21	-7.11	-7.19	-7.02	-6.96	-6.24	26
Borrowings	0.00	0.54	0.67	0.80	0.80	0.79	0.95	0.74	5.53	0.64
Other Liabilities	0.77	0.21	0.02	0.36	0.04	0.06	0.08	0.06	0.09	8.95
Total Liabilities	1.45	0.90	0.71	1.16	0.94	0.86	1.22	1.04	6.58	48
Fixed Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.20	0.18	0.15	1.19
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	1.45	0.90	0.71	1.16	0.93	0.86	1.03	0.86	6.43	47
Total Assets	1.45	0.90	0.71	1.16	0.94	0.86	1.22	1.04	6.58	48

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-0.10	0.09	0.01	0.09	0.01	-0.17	-26
Cash from Investing Activity	0.00	-0.00	-0.00	-0.21	0.65	-0.53	-0.75
Cash from Financing Activity	0.14	0.00	-0.01	0.15	-0.30	5.31	29
Net Cash Flow	0.04	0.09	-0.01	0.03	0.37	4.62	1.95

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	May 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	18.47%	18.47%	18.47%	18.47%	10.63%	10.63%	10.63%	10.63%	10.63%	10.63%	10.63%	10.63%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	81.53%	81.53%	81.53%	81.53%	89.37%	89.37%	89.37%	89.37%	89.37%	89.37%	89.37%	89.37%
Total Shareholders	3,348	3,331	3,336	3,423	3,443	3,545	3,707	3,941	3,861	3,925	3,925	3,883

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Constronics Infra Ltd

Constronics Infra Ltd (CONSTRONIC) is currently trading at 53.49 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Constronics Infra Limited, formerly Invicta Meditek Limited, transitioned from a pharma company to focus on construction and infrastructure. It was established in 1992 and shifted its main objective in 2018. The company engages in various construction projects and trades materials like Blue Metals and M-Sand. This marked a significant pivot from its previous pharmaceutical operations to become a player in infrastructure. Constronics Infra's transition highlights a strategic shift driven by new management objectives, signaling an adaptive and possibly opportunistic approach to market needs. Originally launched a unique BP knee replacement system in 2007, demonstrating prior involvement in medical technology before its strategic pivot.

Over the past 52 weeks, Constronics Infra Ltd has traded between a low of ₹40.70 and a high of ₹70.99. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Constronics Infra Ltd has a market capitalization of approximately 64.24. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Constronics Infra Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 11.20 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 64.24 Cr, Constronics Infra Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Constronics Infra Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Constronics Infra Ltd is 11.20. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Constronics Infra Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

Standalone Profit Loss (in ₹ Crores)

Standalone Balance Sheet (in ₹ Crores)

Standalone Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Constronics Infra Ltd

What is Constronics Infra Ltd share price today?

What does Constronics Infra Ltd do?

What is the 52-week high and low of Constronics Infra Ltd?

What is the market capitalization of Constronics Infra Ltd?

Should I consider investing in Constronics Infra Ltd stock?

Is Constronics Infra Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Constronics Infra Ltd belong to and why does it matter?

What is the PE ratio of Constronics Infra Ltd?

Investor’s Suite

Market Explorer

Market Pulse

Deep Dive

Utility

Company

Technicals

Forecasts

Projection

Frequently Asked Questions about Constronics Infra Ltd

What is Constronics Infra Ltd share price today?

What does Constronics Infra Ltd do?

What is the 52-week high and low of Constronics Infra Ltd?

What is the market capitalization of Constronics Infra Ltd?

Should I consider investing in Constronics Infra Ltd stock?

Is Constronics Infra Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Constronics Infra Ltd belong to and why does it matter?

What is the PE ratio of Constronics Infra Ltd?

Announcements

Oscillators

Neutral

Overall

Bullish

Moving Averages

Bearish

Overall

Bullish

Peers

Price Chart Comparison

Overview

Financial Ratios

Investment Checklist